TY  - GEN
AU  - Schreglmann,S R
AU  - Büchele,F
AU  - Sommerauer,M
AU  - Epprecht,L
AU  - Kägi,G
AU  - Hägele-Link,S
AU  - Götze,O
AU  - Zimmerli,L
AU  - Waldvogel,D
AU  - Baumann,C R
TI  - Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial
SN  - 1468-1331
PY  - 2017///1221
KW  - Aged
KW  - Blood Pressure
KW  - drug effects
KW  - Cholinesterase Inhibitors
KW  - pharmacology
KW  - Cross-Over Studies
KW  - Double-Blind Method
KW  - Female
KW  - Fludrocortisone
KW  - Humans
KW  - Hypotension, Orthostatic
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Parkinson Disease
KW  - Pyridostigmine Bromide
KW  - Quality of Life
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Equivalence Trial; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1111/ene.13260
ER  -